NRXP Stock Price
NRx Pharmaceuticals, Inc.
NRXP stock price is $2.59 (-4.07% on the day), giving NRx Pharmaceuticals, Inc. a market cap of $112.14M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
NRXP Stock Overview
- Price
- $2.59
- Previous close
- $2.70
- Open
- $2.64
- Market cap
- $112.14M
- P/E ratio
- -3.9
- 52-week range
- $1.62 - $5.05
- 1-year price target
- $35.00
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 28
About NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 D-cycloserine and Lurasidone, an oral, fixed dosed combination of D-cycloserine/lurasidone that earned food and drug administration-designated as breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 ketamine, which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior ASIB. The company has a partnership with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; development and manufacturing agreement with Nephron Pharmaceuticals, Inc. and Alcami; license agreement with Apkarian Technologies; development and license agreement with Glytech; license agreement with Sarah Herzog Memorial Hospital. The company was founded in 2015 and is based in Wilmington, Delaware.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NRXP | $2.59 | -4.1% | 695.58K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NRx Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW